Document is current

1188 Antibody substrate oligonucleotide conjugates (ASOCs): a new class of immunotherapeutic agents to inhibit metastasis of tumor cells and block checkpoint inhibition

Crossref DOI link: https://doi.org/10.1136/jitc-2022-SITC2022.1188

Published Online: 2022-11-07

Published Print: 2022-11

Update policy: https://doi.org/10.1136/crossmarkpolicy